Annual Total Debt
$38.10 M
-$5.00 M-11.61%
December 31, 2023
Summary
- As of February 7, 2025, SGMO annual total debt is $38.10 million, with the most recent change of -$5.00 million (-11.61%) on December 31, 2023.
- During the last 3 years, SGMO annual total debt has fallen by -$3.98 million (-9.46%).
- SGMO annual total debt is now -20.75% below its all-time high of $48.08 million, reached on December 31, 2021.
Performance
SGMO Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Debt
$27.73 M
-$1.37 M-4.71%
September 30, 2024
Summary
- As of February 7, 2025, SGMO quarterly total debt is $27.73 million, with the most recent change of -$1.37 million (-4.71%) on September 30, 2024.
- Over the past year, SGMO quarterly total debt has dropped by -$10.38 million (-27.23%).
- SGMO quarterly total debt is now -42.33% below its all-time high of $48.08 million, reached on December 31, 2021.
Performance
SGMO Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Debt Formula
Total Debt = Short Term Debt + Long Term Debt
SGMO Total Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.6% | -27.2% |
| 3 y3 years | -9.5% | -23.2% |
| 5 y5 years | +37.6% | -37.6% |
SGMO Total Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.8% | at low | -42.3% | at low |
| 5 y | 5-year | -20.8% | at low | -42.3% | at low |
| alltime | all time | -20.8% | -100.0% | -42.3% | -100.0% |
Sangamo Therapeutics Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $27.73 M(-4.7%) |
| Jun 2024 | - | $29.10 M(-5.6%) |
| Mar 2024 | - | $30.82 M(-19.1%) |
| Dec 2023 | $38.10 M(-11.6%) | $38.10 M(+8.9%) |
| Sep 2023 | - | $34.98 M(-3.8%) |
| Jun 2023 | - | $36.37 M(-3.5%) |
| Mar 2023 | - | $37.70 M(-12.5%) |
| Dec 2022 | $43.11 M(-10.3%) | $43.11 M(+8.6%) |
| Sep 2022 | - | $39.70 M(-4.4%) |
| Jun 2022 | - | $41.53 M(-3.0%) |
| Mar 2022 | - | $42.81 M(-11.0%) |
| Dec 2021 | $48.08 M(+14.2%) | $48.08 M(+33.1%) |
| Sep 2021 | - | $36.12 M(-3.2%) |
| Jun 2021 | - | $37.33 M(-3.0%) |
| Mar 2021 | - | $38.46 M(-8.6%) |
| Dec 2020 | $42.09 M(-5.2%) | $42.09 M(+10.0%) |
| Sep 2020 | - | $38.26 M(-2.5%) |
| Jun 2020 | - | $39.23 M(-2.4%) |
| Mar 2020 | - | $40.20 M(-9.5%) |
| Dec 2019 | $44.41 M(+60.4%) | $44.41 M(+9.4%) |
| Sep 2019 | - | $40.61 M(-2.3%) |
| Jun 2019 | - | $41.55 M(+212.4%) |
| Mar 2019 | - | $13.30 M(-52.0%) |
| Dec 2018 | $27.69 M(+11.9%) | $27.69 M(+2.8%) |
| Sep 2018 | - | $26.93 M(+2.9%) |
| Jun 2018 | - | $26.18 M(+2.9%) |
| Mar 2018 | - | $25.45 M(+2.9%) |
| Dec 2017 | $24.74 M(+527.1%) | $24.74 M(+539.2%) |
| Sep 2017 | - | $3.87 M(-0.4%) |
| Jun 2017 | - | $3.89 M(-1.0%) |
| Mar 2017 | - | $3.93 M(-0.4%) |
| Dec 2016 | $3.94 M(>+9900.0%) | $3.94 M(+74.9%) |
| Sep 2016 | - | $2.26 M(+813.4%) |
| Jun 2016 | - | $247.00 K(+16.0%) |
| Mar 2016 | - | $213.00 K(>+9900.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Mar 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00(0.0%) |
| Jun 2012 | - | $0.00(0.0%) |
| Mar 2012 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2008 | - | $0.00(0.0%) |
| Jun 2008 | - | $0.00(0.0%) |
| Mar 2008 | - | $0.00(0.0%) |
| Dec 2007 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2007 | - | $0.00(0.0%) |
| Jun 2007 | - | $0.00(0.0%) |
| Mar 2007 | - | $0.00(0.0%) |
| Dec 2006 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2006 | - | $0.00(0.0%) |
| Jun 2006 | - | $0.00(0.0%) |
| Mar 2006 | - | $0.00(0.0%) |
| Dec 2005 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2005 | - | $0.00(0.0%) |
| Jun 2005 | - | $0.00(0.0%) |
| Mar 2005 | - | $0.00(0.0%) |
| Dec 2004 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2004 | - | $0.00(0.0%) |
| Jun 2004 | - | $0.00(0.0%) |
| Mar 2004 | - | $0.00(0.0%) |
| Dec 2003 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2003 | - | $0.00(0.0%) |
| Jun 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) |
| Dec 2002 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2002 | - | $0.00(-100.0%) |
| Jun 2002 | - | $234.00 K(-56.3%) |
| Mar 2002 | - | $536.00 K(+88.1%) |
| Dec 2001 | $285.00 K(>+9900.0%) | $285.00 K(>+9900.0%) |
| Sep 2001 | - | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) |
| Dec 2000 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2000 | - | $0.00(0.0%) |
| Jun 2000 | - | $0.00(-100.0%) |
| Mar 2000 | - | $12.62 M |
| Dec 1999 | $300.00 K(>+9900.0%) | - |
| Dec 1998 | $0.00(0.0%) | - |
| Dec 1997 | $0.00(0.0%) | - |
| Dec 1996 | $0.00 | - |
FAQ
- What is Sangamo Therapeutics annual total debt?
- What is the all time high annual total debt for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual total debt year-on-year change?
- What is Sangamo Therapeutics quarterly total debt?
- What is the all time high quarterly total debt for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly total debt year-on-year change?
What is Sangamo Therapeutics annual total debt?
The current annual total debt of SGMO is $38.10 M
What is the all time high annual total debt for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual total debt is $48.08 M
What is Sangamo Therapeutics annual total debt year-on-year change?
Over the past year, SGMO annual total debt has changed by -$5.00 M (-11.61%)
What is Sangamo Therapeutics quarterly total debt?
The current quarterly total debt of SGMO is $27.73 M
What is the all time high quarterly total debt for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly total debt is $48.08 M
What is Sangamo Therapeutics quarterly total debt year-on-year change?
Over the past year, SGMO quarterly total debt has changed by -$10.38 M (-27.23%)